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Segregated calcium stores are important for stretch-induced calcium
signaling in smooth muscle cells: implication in pulmonary hypertension
Guillaume Gilbert, Thomas Ducret, Jean-Pierre Savinea, Roger Marthan,
Jean-François Quignard
Université de Bordeaux, Centre de Recherche Cardio-Thoracique,
INSERM U1045, Bordeaux, France
Pulmonary arterial smooth muscle cells (PASMC) are submitted to stretch
forces exerted by the blood pressure. They can transduce a mechanical stim-
ulus of stretch into a biological response of contraction, a mechanism called
myogenic tone which involves Ca2+ influx through stretch-activated channels
(SAC). We investigate how the subcellular organization of Ca2+ stores in
PASMC (sarcoplasmic reticulum (SR), lysosomes and mitochondria) is impor-
tant for the Ca2+ response to stretch during PH.
Studies were performed in freshly isolated PASMC from control rats and
rats with a pulmonary hypertension induced by an injection of monocrotaline
(MCT). Inward currents from SAC were recorded after a negative pressure
applied by a patch-clamp pipette. Cytosolic Ca2+ was also measured with the
fluo4 probe and mitochondrial Ca2+ with the rhod2 probe after an osmotic
shock. A pharmacological approach coupled with different coimmuno-
labelings of ryanodine receptors (RyR) and SERCA2 pumps was used to
investigate which RyR subtype is involved in Ca2+ response to stretch.
PASMC exhibit segregated Ca2+ stores: a subplasmalemnal SR store with
RyR1 and SERCA2b, associated to mitochondria and a perinuclear SR store
with RyR3 and SERCA2a. We showed that a stretch of PASMC induces an
inward Ca2+ influx through SAC that is amplified by a Ca2+ release by RyR1,
which is buffered by mitochondria. In MCT rats, the subcellular organization of
RyR subtypes is modified: RyR3 and SERCA2a are not only expressed in a
perinuclear area but also in a subplasmalemnal level. This is correlated with a
different organization of mitochondria. In MCT rats, this new organisation leads
to a greater amplification by all RyR subtypes and to a higher Ca2+ increase
induced by stretch. Furthermore, the Ca2+ response to stretch is enhanced by a
mechanism independent on extracellular Ca2+, involving caveolae.
The spatial organization of Ca2+ stores in PASMC is important for cell sig-
naling and plays a causal role in PH.
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Vascular smooth muscle mineralocorticoid receptor contributes to
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Aims: Because mineralocorticoid receptor (MR) antagonists have shown effi-
cacy in slowing down the progression of heart failure after myocardial infarction
(MI), there is interest to elucidate the cell-specific involvement of MR. Indeed, the
role of MR in vascular smooth muscle cells (VSMC) in heart failure, especially its
impact on coronary circulation, has never been investigated.
Methods and Results: Two months after MI, mice lacking the MR specifi-
cally in VSMC (MI-MRSMKO) and mice treated with the MR antagonist finere-
none (MI-fine) had better coronary function than control (MI-CTL), as assessed
by acetylcholine-induced relaxation of isolated arteries (relaxation %: MI-CTL:
36±5, MI-MRSMKO: 54±3, MI-fine: 76±4; P<0.05). Furthermore, MRI showed
that the coronary reserve was increased (ml/mg/min: MI-CTL: 1.1±0.5, MI-
MRSMKO: 4.6±1.6, P<0.05; MI-fine: 3.6±0.7, P<0.01). Incubation with the
NAPDH-oxidase inhibitor apocynin of coronary arteries improved acetylcholine-
induced relaxation in MI-CTL to a higher extent than in MI-MRSMKO and MI-
fine mice, suggesting that MR antagonism reduces oxidative stress-mediated
endothelial dysfunction. Indeed, incubation of coronary arteries from non-infarcted
animals with 10-9M angiotensin II induced oxidative stress and impaired acetyl-
choline-induced relaxation in CTL mice, but not in MRSMKO or in 4 weeks
finerenone-treated mice. These improvements in coronary function were accompa-
nied in MI-MRSMKO mice by reduced LV fibrosis and improved LV function.
Conclusion: After MI, VSMC-specific MR invalidation benefits LV dys-
function, likely through improvement of coronary reserve and of coronary
endothelial function, demonstrating for the first time the deleterious role of
smooth muscle MR activation in heart failure. Furthermore, systemic MR
blockade by finerenone confers additional functional improvements.
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Contribution of large conductance Ca(2+)-activated K(+) channels to
vasorelaxation induced by cAMP-phosphodiesterases inhibitors is
blunted in coronary arteries from rats with heart failure
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3’-5’-cyclic adenosine monophosphate (cAMP) is an important mediator of
vasorelaxation. In vascular smooth muscle, cellular cAMP concentrations are
mainly regulated by type 3 and 4 phosphodiesterases (PDE3 & PDE4). Large
conductance Ca(2+)-activated K(+) (BK) channels are reported to mediate
cAMP-induced relaxation. Here, we sought to clarify whether BK channels are
key players in the regulation of tone by PDE activities in rat coronary arteries
(CA), and if this contribution is altered in congestive heart failure (CHF). CA
were isolated from rats with CHF sacrificed 22 weeks after surgical stenosis of
the ascending aorta. Age-matched « sham » animals were used as controls. CA
were isolated and mounted on a myograph. Maximal contraction was obtained
using high K(+) solution. Relaxations induced by inhibitors of PDE4 (Ro-20
1724, Ro, 10μM) or the PDE3 (Cilolstamide, Cil, 1μM) were studied in CA con-
tracted with the thromboxane analogue U46619 (1-2μM) and incubated or not
with iberiotoxin (IBTX, 100nM), a selective BK channel blocker. CA isolated
from rats displaying robust signs of CHF showed a 78% reduction of maximal
contraction (P<0.001, N=5-7) and reduced relaxing response to acetylcholine
(–55%, P< 0.01), compared to CA from sham rats. Ro and Cil relaxed sham CA
to respectively 31±13% and 14±5% of U46619 tone (N=6). In the presence of
IBTX, these responses decreased to 3±1% (N=5, P<0.05) and 4±3% (N=4). In
CHF rats, Ro relaxed CA to 7±4% and Cil to 27±4% (N=4), whereas IBTX had
no effect either on responses to Ro (17±8 %, N=5) or Cil (26±6%, N=4). Simul-
taneous addition of Cil and Ro relaxed sham CA to 79±10% (N=7), an effect
reduced by IBTX (20±9%, N=6, P<0.01). Interestingly, Cil and Ro together
relaxed CHF CA to 69±9% but this was not altered by IBTX (69±14%, N=5-6).
These results show that, in rat CA, BK channels are important effectors of
relaxing responses to PDE3 and PDE4 inhibition. In CHF, specific contribution
of BK channels to these responses is lost.
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Regulating O-GlcNAcylation by AMP-activated protein kinase, a new
way to prevent hypertrophy development
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Background: We have previously shown that the AMPK specific acti-
vator, A769662, is able to block phenylephrine (PE)-induced hypertrophy
without affecting the previously identified AMPK-related key regulators of
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